Your browser doesn't support javascript.
loading
Systematic Review of Long Term Sinonasal Outcomes in CRSwNP after Endoscopic Sinus Surgery: A call for Unified and Standardized Criteria and Terms.
Rodriguez-Van Strahlen, Camilo; Arancibia, Claudio; Calvo-Henriquez, Christian; Mullol, Joaquim; Alobid, Isam.
Affiliation
  • Rodriguez-Van Strahlen C; Rhinology and Skull Base Unit, Department of Oto rhinolaryngology, Hospital Clinic Barcelona, Barcelona, Spain. carodriguezv@clinic.cat.
  • Arancibia C; Universitat de Barcelona, Barcelona, Spain. carodriguezv@clinic.cat.
  • Calvo-Henriquez C; Rhinology and Skull Base Unit, Department of Oto rhinolaryngology, Hospital Clinic Barcelona, Barcelona, Spain.
  • Mullol J; Service of Otolaryngology, Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain.
  • Alobid I; Rhinology and Skull Base Unit, Department of Oto rhinolaryngology, Hospital Clinic Barcelona, Barcelona, Spain.
Article in En | MEDLINE | ID: mdl-38913122
ABSTRACT
PURPOSE OF REVIEW To present current evidence in long-term (> 5 years) results after endoscopic sinus surgery (ESS) focusing on Patients Reported Outcome Measures (PROMs) and other sinonasal outcomes while assessing the role of ESS in the treatment of CRSwNP, and identifying outcomes which affect the results of ESS and defining recommendations for future studies. RECENT

FINDINGS:

Long-term results of ESS in CRSwNP can be branched in PROMs and other objective measurements. Despite the heterogeneity of reported outcomes make it difficult to perform comparisons and meta-analysis, ESS improves PROMs, including symptoms, QOL and olfaction. Objectives outcomes such as NPS, LMS, type of surgery, or recurrence and revision surgery don't have a clear role in long-term results. Clustering patients suggest asthma, N-ERD, allergy, eosinophil count and IL-5 could have a role in predicting recurrence and severe disease. Long-term studies of CRSwNP treated with ESS are scarce. There is a significant need to standardize the report of results. The use of tools as SNOT-22, NPS, validated smell tests, defined criteria for disease recurrence and control and ESS extension in a unified systematic way could allow better comparisons between treatments in the new era of biologics.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Curr Allergy Asthma Rep Journal subject: ALERGIA E IMUNOLOGIA Year: 2024 Document type: Article Affiliation country: España

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Curr Allergy Asthma Rep Journal subject: ALERGIA E IMUNOLOGIA Year: 2024 Document type: Article Affiliation country: España